Transcode Therapeutics Inc
NASDAQ:RNAZ
Transcode Therapeutics Inc
NASDAQ:RNAZ
Price:
1.8
USD
4.05%
Market Cap:
$29.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Transcode Therapeutics Inc
NASDAQ:RNAZ
|
US |
|
N
|
Nxera Pharma Co Ltd
F:JSS
|
JP |
Shareholder Yield
Current shareholder yield for RNAZ is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
RNAZ Price
Transcode Therapeutics Inc
Transcode Therapeutics Inc
Annual Price Range
1.8
52w Low
1.545
52w High
15.23
Price Metrics
| Average Annual Return | -82.78% |
| Standard Deviation of Annual Returns | 20.87% |
| Max Drawdown | -100% |
Shares Statistics
| Market Capitalization | 29.9m USD |
| Shares Outstanding | 16 608 247 |
| Percentage of Shares Shorted | 5.56% |
RNAZ Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
RNAZ's latest stock split occurred on May 15, 2025
The company executed a 1-for-28 stock split, meaning that for every 28 shares held, investors received 1 new share.
Before the split, RNAZ traded at 0.3467 per share. Afterward, the share price was about 7.65.
The adjusted shares began trading on May 15, 2025. This was stock split number 4 in RNAZ's history, following the previous one in Dec 4, 2024.
Pre-Split Price
9.7076
0.3467
Post-Split Price
7.65
Before
After